AB3A trade ideas
Sarepta Therapeutics: Major Monthly Signal on WatchWe have an inverted H&S here on the monthly time frame above a major level representing all time highs in year 2000. That is very bullish on a long term basis.
Some people have asked in the past if inverted H&S patterns are only reversal patterns. I've spoken to Peter Brandt (my mentor in classical charting principles) about this several times - according to Schabacker (founder of classical charting) they are valid continuation patterns.
In other good news. I've had a decent level of interest for a trading room. For those that still haven't seen those posts, I'll be starting a live trading room for free on the first week of January. I'll showcase my trade management which is the most important aspect of trading. (Active day trades/swings trades/etc). DMs are open if interested in joining. I'll send everyone that DMs me an invite to the room a day or two before it launches (January 4th).
It's a disaster: SRPTThe market teaches traders lessons every day... often times reinforcing them to seasoned traders like myself. I happened to have been in but was out of NASDAQ:SRPT before this disaster today. It's a reminder why you MUST take profits even if sometimes you feel the FOMO after you do...
SRPT, Histogram just turned negativeThis is a Bearish indicator signaling SRPT's price could decline from here. Traders may explore shorting the stock or put options. Tickeron's A.I. dvisor identified 44 similar cases where SRPT's MACD histogram became negative, and 35 of them led to successful outcomes. Odds of Success: 80%. Current price $170.73 is above $168.81 the highest support line found by Tickeron A.I. Throughout the month of 11/27/20 - 12/30/20, the price experienced a +23% Uptrend, while the week of 12/22/20 - 12/30/20 shows a -4% Downtrend.
Bearish Trend Analysis
The 10-day RSI Indicator for SRPT moved out of overbought territory on December 28, 2020. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In 38 of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Indicator may be shifting from an upward trend to a downward trend. In 46 of 68 cases where SRPT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for SRPT turned negative on December 30, 2020. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 35 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
SERAPTA THERAPEUTICS PostHey people, SERAPTA THERAPEUTICS is in a very important moment in its history we can attend a higher historical. It is in a bullish dynamic with a return of purchase volume made and a hammer candle shape. On the TIMEFRAME M1 we see a gravestone with a high volume of purchases exchanged it came back tested the zone of equilibrium. It will make a trend reversal on the last previous lower big propability to breakout the price. At the same time the zone to join a new one and go to the next top (See TIMEFRAME H1) to make a test. Either turn around or go for a next all-time high with a test before breakout ahead of the equilibrium zone and go to test the top of the bullish channel.
Please LIKE & FOLLOW, thank you!
SRPT holds Support a second timeAfter earnings NASDAQ:SRPT tanked HARD to what was a prior support at 126.53 where I had entered back in September. I watched this closely with a residual positions to see if it would hold it or break the level. I wanted to have some skin in the game for SRPT to retest the highs for the long term. So far today it looks to be holding that level as it has retraced a full 50% of the post-earning drop.
Marking this up for posterity as a collection of examples for the 50% retracement levels being a powerful signal of Support and Resistance.
SRPT, MACD Histogram just turned positiveThis is a Bullish indicator signaling SRPT's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I. dvisor identified 41 similar cases where SRPT's MACD histogram became positive, and 33 of them led to successful outcomes. Odds of Success: 80%. Current price $135.72 crossed the support line at $134.67 and is trading between $138.50 support and $134.67 support lines. Throughout the month of 10/26/20 - 11/25/20, the price experienced a -2% Downtrend, while the week of 11/18/20 - 11/25/20 shows a +2% Uptrend.
Bullish Trend Analysis
The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. Tickeron A.I. detected that in 41 of 49 cases where SRPT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for SRPT just turned positive on November 25, 2020. Looking at past instances where SRPT's MACD turned positive, the stock continued to rise, Tickeron A.I. detected that in 33 of 41 cases over the following month. The odds of a continued upward trend are 80%.
Following a +0.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRPT advanced for three days, in 279 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SRPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SRPT 2D: XABCD BEARS / 40% correction next(NEW/UPDATED)Why get subbed to to me on Tradingview?
-TOP author on TradingView
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-24/7 uptime so constant updates
SRPT 2D: XABCD BEARS / 40% correction next(NEW/UPDATED)
IMPORTANT NOTE: speculative setup. do your own
due dill. use STOP LOSS. don't overleverage.
🔸 Summary and potential trade setup
::: SRPT 2days/candle chart review
::: XABCD BEARS
::: 40% correction up next
::: point D / PRZ near 180/182
::: get ready to short for gains
::: TP1 is 30% gains
::: TP2 is 40% gains
::: strategy: short from PRZ
::: correction can last 4-10 weeks
::: market disconnected from reality
::: don't get crushed in this new correction
::: good luck traders
🔸 Supply/Demand Zones
::: N/A
::: N/A
🔸 Other noteworthy technicals/fundies
::: TD9/Combo update: N/A
::: Sentiment: BEARS
::: Sentiment outlook short-term: BEARISH
SRPT 16H: XABCD BEARS / 40% correction next(NEW)Why get subbed to to me on Tradingview?
-TOP author on TradingView
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-24/7 uptime so constant updates
SRPT 16H: XABCD BEARS / 40% correction next(NEW)
IMPORTANT NOTE: speculative setup. do your own
due dill. use STOP LOSS. don't overleverage.
🔸 Summary and potential trade setup
::: SRPT 16hour chart review
::: XABCD BEARS
::: 40% correction up next
::: point D / PRZ near 172/174
::: get ready to short for gains
::: TP1 is 30% gains
::: TP2 is 40% gains
::: strategy: short from PRZ
::: correction can last 4-8 weeks
::: good luck traders
🔸 Supply/Demand Zones
::: N/A
::: N/A
🔸 Other noteworthy technicals/fundies
::: TD9/Combo update: N/A
::: Sentiment: BEARS
::: Sentiment outlook short-term: BEARISH